These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21135313)

  • 1. Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder.
    Perlis RH; Uher R; Ostacher M; Goldberg JF; Trivedi MH; Rush AJ; Fava M
    Arch Gen Psychiatry; 2011 Apr; 68(4):351-60. PubMed ID: 21135313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposed DSM-5 mixed features are associated with greater likelihood of remission in out-patients with major depressive disorder.
    Perlis RH; Cusin C; Fava M
    Psychol Med; 2014 May; 44(7):1361-7. PubMed ID: 22417535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population.
    Kamat SA; Rajagopalan K; Pethick N; Willey V; Bullano M; Hassan M
    J Manag Care Pharm; 2008 Sep; 14(7):631-42. PubMed ID: 18774873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinically useful self-report measure of the DSM-5 mixed features specifier of major depressive disorder.
    Zimmerman M; Chelminski I; Young D; Dalrymple K; Martinez JH
    J Affect Disord; 2014 Oct; 168():357-62. PubMed ID: 25103631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes.
    Davis LL; Wisniewski SR; Howland RH; Trivedi MH; Husain MM; Fava M; McGrath PJ; Balasubramani GK; Warden D; Rush AJ
    Drug Alcohol Depend; 2010 Mar; 107(2-3):161-70. PubMed ID: 19945804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual satisfaction and quality of life in major depressive disorder before and after treatment with citalopram in the STAR*D study.
    Ishak WW; Christensen S; Sayer G; Ha K; Li N; Miller J; Nguyen JM; Cohen RM
    J Clin Psychiatry; 2013 Mar; 74(3):256-61. PubMed ID: 23561231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of Life, Functioning, and Depressive Symptom Severity in Older Adults With Major Depressive Disorder Treated With Citalopram in the STAR*D Study.
    Steiner AJ; Recacho J; Vanle B; Dang J; Wright SM; Miller JS; Kauzor K; Reid M; Bashmi LE; Mirocha J; Danovitch I; IsHak WW
    J Clin Psychiatry; 2017 Jul; 78(7):897-903. PubMed ID: 28858443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study.
    Angst J; Azorin JM; Bowden CL; Perugi G; Vieta E; Gamma A; Young AH;
    Arch Gen Psychiatry; 2011 Aug; 68(8):791-8. PubMed ID: 21810644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D data.
    Sakurai H; Suzuki T; Yoshimura K; Mimura M; Uchida H
    Psychopharmacology (Berl); 2017 Aug; 234(16):2453-2461. PubMed ID: 28470399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward a validation of a new definition of agitated depression as a bipolar mixed state (mixed depression).
    Benazzi F; Koukopoulos A; Akiskal HS
    Eur Psychiatry; 2004 Apr; 19(2):85-90. PubMed ID: 15051107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of bipolar depression versus major depressive disorder in large multicenter trials.
    Perlis RH; Brown E; Baker RW; Nierenberg AA
    Am J Psychiatry; 2006 Feb; 163(2):225-31. PubMed ID: 16449475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bipolar polygenic loading and bipolar spectrum features in major depressive disorder.
    Wiste A; Robinson EB; Milaneschi Y; Meier S; Ripke S; Clements CC; Fitzmaurice GM; Rietschel M; Penninx BW; Smoller JW; Perlis RH
    Bipolar Disord; 2014 Sep; 16(6):608-16. PubMed ID: 24725193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.
    Howland RH; Rush AJ; Wisniewski SR; Trivedi MH; Warden D; Fava M; Davis LL; Balasubramani GK; McGrath PJ; Berman SR
    Drug Alcohol Depend; 2009 Jan; 99(1-3):248-60. PubMed ID: 18986774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report.
    Nierenberg AA; Husain MM; Trivedi MH; Fava M; Warden D; Wisniewski SR; Miyahara S; Rush AJ
    Psychol Med; 2010 Jan; 40(1):41-50. PubMed ID: 19460188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary versus specialty care outcomes for depressed outpatients managed with measurement-based care: results from STAR*D.
    Gaynes BN; Rush AJ; Trivedi MH; Wisniewski SR; Balasubramani GK; McGrath PJ; Thase ME; Klinkman M; Nierenberg AA; Yates WR; Fava M
    J Gen Intern Med; 2008 May; 23(5):551-60. PubMed ID: 18247097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of Life and Functioning in Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder After Treatment With Citalopram Monotherapy.
    Steiner AJ; Boulos N; Mirocha J; Wright SM; Collison KL; IsHak WW
    Clin Neuropharmacol; 2017; 40(1):16-23. PubMed ID: 27764051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What predicts attrition in second step medication treatments for depression?: a STAR*D Report.
    Warden D; Rush AJ; Wisniewski SR; Lesser IM; Kornstein SG; Balasubramani GK; Thase ME; Preskorn SH; Nierenberg AA; Young EA; Shores-Wilson K; Trivedi MH
    Int J Neuropsychopharmacol; 2009 May; 12(4):459-73. PubMed ID: 18611293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.